InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by McFarlane Neil F., 董事长兼首席执行官. Director active across 3 companies, notably Adamas Pharmaceuticals Inc. Cumulatively, 10 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €463k. History available since 24 November 2021. The latest transaction was disclosed on 13 February 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
McFarlane Neil F. is Président-Directeur Général. He has 10 filings in total, and across the 10 sampled filings, they run from 2021-11-24 to 2026-02-10, with EUR 0 of buys and EUR 463269 of sales, mainly at ZEVRA THERAPEUTICS, INC., as well as one filing at COLLEGIUM PHARMACEUTICAL, INC.